Shorted $EIX.
96% long by 34% short. 24% long Health Care, 6% long Public Utilities, 6% long Technology, 6% long Capital Goods, 6% long Consumer Non-Durables, 7% long Consumer Services, 6% long Energy, 7% short Finance. See current positions.

Covered $BX (+6.6%).
97% long by 27% short. 24% long Health Care, 6% long Public Utilities, 6% long Technology, 6% long Capital Goods, 6% long Consumer Non-Durables, 7% long Consumer Services, 6% long Energy. See current positions.

Sold $CYH (+23.2%).
89% long by 33% short. 24% long Health Care, 13% long Public Utilities, 6% long Capital Goods, 6% long Consumer Non-Durables, 7% long Consumer Services, 6% long Energy, 7% short Finance, 7% short Consumer Durables. See current positions.

Sold $HYG (-1%).
82% long by 33% short. 24% long Health Care, 13% long Public Utilities, 6% long Capital Goods, 6% long Consumer Non-Durables, 7% long Consumer Services, 6% long Energy, 6% short Finance, 7% short Consumer Durables. See current positions.

Bought $EPAY.
90% long by 34% short. 24% long Health Care, 13% long Public Utilities, 7% long Technology, 6% long Capital Goods, 6% long Consumer Non-Durables, 7% long Consumer Services, 6% long Energy, 7% short Finance, 7% short Consumer Durables. See current positions.

Bought $KURA.
99% long by 34% short. 31% long Health Care, 14% long Public Utilities, 6% long Capital Goods, 6% long Consumer Non-Durables, 8% long Consumer Services, 7% long Energy, 7% short Finance, 7% short Consumer Durables. See current positions.

Sold $BLMN (-6.7%).
97% long by 29% short. 25% long Health Care, 14% long Technology, 14% long Public Utilities, 8% long Consumer Services, 8% long Energy, 7% short Consumer Durables, 7% long Capital Goods, 7% short Finance, 7% long Consumer Non-Durables. See current positions.

Basically went fully invested in just the last few days, so it looks like long everything except Finance and Consumer Durables going into the US elections.

I like it

Bought $OUT, $ATEX.
81% long by 21% short. 24% long Health Care, 14% long Public Utilities, 8% long Consumer Services, 7% long Energy, 7% long Capital Goods, 7% short Finance, 7% long Consumer Non-Durables. See current positions.

Bought $BLMN, $FISV.
Shorted $RBC.
96% long by 28% short. 25% long Health Care, 15% long Consumer Services, 14% long Public Utilities, 7% long Energy, 7% short Finance, 7% long Capital Goods, 7% short Consumer Durables, 7% long Technology, 7% long Consumer Non-Durables. See current positions.

Covered $VNE (-30%).
60% long by 21% short. 25% long Health Care, 7% long Capital Goods, 7% short Finance, 7% long Public Utilities, 7% long Consumer Non-Durables. See current positions.

$NTGR from yesterday just beat on earnings. Nov $38 calls the system followed are now in the money.

Bought $BHVN.
46% long by 16% short. 25% long Health Care, 7% long Consumer Non-Durables. See current positions.

Bought $SKY, $NTGR.
Shorted $BX.
60% long by 23% short. 25% long Health Care, 7% short Finance, 7% long Basic Industries, 7% long Public Utilities, 7% long Consumer Non-Durables. See current positions.

Bought $CYH.
48% long by 17% short. 26% long Health Care, 7% long Consumer Non-Durables. See current positions.

Top gain today from long $GLYC (+3%).
48% long by 16% short. 26% long Health Care, 7% long Consumer Non-Durables. See current positions.

Bought $PM.
33% long by 16% short. 19% long Health Care, 7% long Consumer Non-Durables, 7% short Consumer Services. See current positions.

Shorted $JEF.
Sold $FOXA (+4.1%).
34% long by 23% short. 18% long Health Care, 7% short Consumer Services. See current positions.

Top gain today from long $CNR (+8%).
34% long by 16% short. 18% long Health Care. See current positions.

Top gains today from long $FOXA (+4%), long $NVST (+3%).
41% long by 16% short. 18% long Health Care. See current positions.

$FOXA just got upgraded with price target raised from $31 to $39 by BofA Securities, so that might have been the reason for the weekly calls bought on Friday.
https://www.benzinga.com/analyst-ratings/analyst-color/20/10/17823456/fox-is-an-under-the-radar-play-on-us-sports-gambling#/

GlycoMimetics's Sickle Cell Disease Drug Gets Rare Pediatric Disease Designation

GlycoMimetics Inc (NASDAQ:GLYC) said the FDA has granted rare pediatric disease designation for rivipansel in the treatment of sickle cell disease in patients 18 and younger.

The stock was gaining 8.56% to $3.55 premarket Tuesday.



But stock falling on big share offering  



GlycoMimetics May Sell Up to $100 Million Shares via Cowen - Stock Down Near 4% After-Hours


Sent from my iPhone

>